IDEXX LABORATORIES INC /DE (IDXX)
IDEXX LABORATORIES INC /DE (IDXX) public financial performance, SEC filing summary, and valuation metrics.
Financial highlights
- Gross Profit: 722739000 usd (2026-03-31)
- Net Income: 278446000 usd (2026-03-31)
- Operating Income: 362586000 usd (2026-03-31)
- Contract Revenue: 666124000 usd (2026-03-31)
- Operating Income: 1360031000 usd (2025-12-31)
- Gross Profit: 2659579000 usd (2025-12-31)
- Contract Revenue: 2539210000 usd (2025-12-31)
- Net Income: 1059464000 usd (2025-12-31)
- Contract Revenue: 656159000 usd (2025-09-30)
- Operating Income: 354846000 usd (2025-09-30)
- Gross Profit: 683354000 usd (2025-09-30)
- Net Income: 274610000 usd (2025-09-30)
- Net Income: 293989000 usd (2025-06-30)
- Contract Revenue: 657561000 usd (2025-06-30)
- Gross Profit: 694732000 usd (2025-06-30)
- Operating Income: 373046000 usd (2025-06-30)
- Net Income: 242677000 usd (2025-03-31)
- Gross Profit: 623379000 usd (2025-03-31)
- Contract Revenue: 573051000 usd (2025-03-31)
- Operating Income: 316534000 usd (2025-03-31)
Valuation snapshot
- market cap: 41698050000
- pe ratio: 38.66252697